Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites

Journal of Virology

Volumn 74, Issue 22, 2000, Pages 10269-10273

  Leigh Brown, A J ^a   Precious, H M ^a   Whitcomb, J M ^a   Wong, J K ^a   Quigg, M ^a   Huang, W ^a   Daar, E S ^a   D'Aquila, R T ^a   Keiser, P H ^a   Connick, E ^a   Hellmann, N S ^a   Petropoulos, C J ^a   Richman, D D ^a   Little, S J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DELAVIRDINE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONSENSUS SEQUENCE; GENE MUTATION; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHENOTYPE; PHYLOGENY; REVERSE TRANSCRIPTASE INHIBITORS; VARIATION (GENETICS);

EID: 0033755359     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.22.10269-10273.2000     Document Type: Article

References (26)

1. Transmission of zidovudine-resistant HIV-1 through heterosexual contacts
2. HIV-1 drug resistance in newly infected individuals
3. Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance
4. Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: Antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome
5. Primary infection with zidovudine-resistant human immunodeficiency virus type 1
6. Evolutionary trees from DNA sequences: A maximum likelihood approach
7. PHYLIP - Phylogeny inference package (version 3.2)
8. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
9. Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the nonnucleoside inhibitor HBY 097: Inhibitor flexibility is a useful design feature for reducing drug resistance
10. Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year
11. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA
12. Reduced antiretroviral drug susceptibility among patients with primary HIV infection
13. Dual resistance to zidovudine and lamivudine in patients treated with zidovudine-lamivudine combination therapy: Association with therapy failure
14. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
15. Transmission of 215 mutants in primary HIV infection and analysis after 6 months of zidovudine
16. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
17. Multiple regression analysis of sequence variants in HIV-1 reverse transcriptase at onset of antiretroviral therapy can predict long term virological response
18. Mutations associated with zidovudine resistance in HIV-1 among recent seroconvertors
19. The neighbor-joining method: A new method for reconstructing phylogenetic trees
20. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use
21. The 'megaprimer' method of site-directed mutagenesis
22. Mutations in retroviral genes associated with drug resistance
23. The genetic data environment and expandable GUI for multiple sequence analysis
24. TREECON for Windows: A software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment
25. Transmission of antiretroviral-drug-resistant HIV-1 variants